Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?

We are delighted having caused an editorial with regard to our paper on single nucleotide polymorphisms (SNPs) and neoadjuvant treatment toxicity of FLOT within locally advanced gastric and gastroesophageal junction cancer (1,2)